Accession Number:
ADA361863
Title:
Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin With Liposomal-Annamycin.
Descriptive Note:
Annual rept. 23 Sep 97-22 Sep 98
Corporate Author:
M D ANDERSON CANCER CENTER HOUSTON TX
Personal Author(s):
Report Date:
1998-10-01
Pagination or Media Count:
7.0
Abstract:
Nine patients with metastatic breast carcinoma refractory to doxorubicin were entered in a Phase II study of liposomal-annamycin, a new anthracycline antibiotic which has shown ability to circumvent multidrug resistance. A total of 14 doses of liposomal- annamycin were given at three different dose levels. Toxicity was mild and limited to granulocytopenia in less than 50 of patients. No antitumor responses were seen.
Descriptors:
Subject Categories:
- Medicine and Medical Research